MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma

[1]  Y. Liu,et al.  MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1 , 2018, Cell Death & Disease.

[2]  Zhiwei Zhang,et al.  MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer. , 2017, Life sciences.

[3]  Bin Zhou,et al.  Integrated genomic characterization of cancer genes in glioma , 2017, Cancer Cell International.

[4]  Andrea D. Olmstead,et al.  Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9 , 2017, EBioMedicine.

[5]  Jia Wen Liang,et al.  Promoter hypermethylation‐mediated downregulation of miR‐770 and its host gene MEG3, a long non‐coding RNA, in the development of gastric cardia adenocarcinoma , 2017, Molecular carcinogenesis.

[6]  J. Wang,et al.  Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway , 2017, Oncogenesis.

[7]  L. Zhao,et al.  MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2–ERK1/2 signaling pathway by upregulating GIT1 , 2017, Oncogenesis.

[8]  Jang Th,et al.  miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway , 2017 .

[9]  C. Chuang,et al.  miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway , 2017, Oncogenesis.

[10]  Chen Huang,et al.  MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways , 2017, EBioMedicine.

[11]  Yan Shi,et al.  MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D. , 2017, American journal of cancer research.

[12]  R. Gu,et al.  MicroRNA-101 inhibits proliferation, migration and invasion in osteosarcoma cells by targeting ROCK1. , 2017, American journal of cancer research.

[13]  Katharine A McNeill,et al.  Epidemiology of Brain Tumors. , 2016, Neurologic clinics.

[14]  J. Ajani,et al.  H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer , 2016, EBioMedicine.

[15]  S. Duensing,et al.  Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer , 2016, Clinical Cancer Research.

[16]  C. Peng,et al.  MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2 , 2016, Oncotarget.

[17]  J. Eun,et al.  NKX6.3 Is a Transcription Factor for Wnt/β-catenin and Rho-GTPase Signaling-Related Genes to Suppress Gastric Cancer Progression , 2016, EBioMedicine.

[18]  B. Maček,et al.  A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib , 2016, EBioMedicine.

[19]  Maryam K. Mohammed,et al.  Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance , 2016, Genes & diseases.

[20]  Xin Yu,et al.  Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma , 2016, Tumor Biology.

[21]  Cheng-yong Guo,et al.  Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2. , 2015, International journal of oncology.

[22]  A. Reyniès,et al.  Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma , 2015, Oncogenesis.

[23]  Xin Chen,et al.  The association between Salt-inducible kinase 2 (SIK2) and gamma isoform of the regulatory subunit B55 of PP2A (B55gamma) contributes to the survival of glioma cells under glucose depletion through inhibiting the phosphorylation of S6K , 2015, Cancer Cell International.

[24]  Ziwei Wang,et al.  Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway. , 2015, Cancer letters.

[25]  Y. Liu,et al.  Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1 , 2015, Oncogene.

[26]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[27]  S. Cohen,et al.  miRNAs and aging: A genetic perspective , 2014, Ageing Research Reviews.

[28]  N. Kotaja,et al.  MicroRNAs and spermatogenesis. , 2014, Fertility and sterility.

[29]  I. Eisenberg,et al.  Regulatory role of microRNAs in ovarian function. , 2014, Fertility and sterility.

[30]  T. Song,et al.  miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2 , 2014, Digestive Diseases and Sciences.

[31]  Deng-feng Li,et al.  MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. , 2014, International journal of clinical and experimental medicine.

[32]  Í. Lopes-Cendes,et al.  The new world of RNAs , 2013, Genetics and molecular biology.

[33]  X. F. Wang,et al.  MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells. , 2013, Cellular and molecular biology.

[34]  Xia Li,et al.  Comprehensive analysis of the functional microRNA–mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression , 2013, Nucleic acids research.

[35]  R. Shi,et al.  Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1. , 2013, Current pharmaceutical design.

[36]  M. Demma,et al.  CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation , 2013, Oncogene.

[37]  C. Chen,et al.  Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. , 2013, Cancer biotherapy & radiopharmaceuticals.

[38]  Jie Zhou,et al.  Tumor-suppressive effects of CDK8 in endometrial cancer cells , 2013, Cell cycle.

[39]  C. Godfraind,et al.  MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes , 2011, PloS one.

[40]  Sung-Chul Lim,et al.  Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma. , 2011, International journal of oncology.

[41]  K. Somasundaram,et al.  Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma , 2010, Modern Pathology.

[42]  Y. Shoshan,et al.  Gliomas display a microRNA expression profile reminiscent of neural precursor cells. , 2010, Neuro-oncology.

[43]  Sho Fujisawa,et al.  Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways , 2009, Cell.

[44]  Li-Huei Tsai,et al.  Cyclin-dependent kinases: a family portrait , 2009, Nature Cell Biology.

[45]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[46]  Jun-Yuan Ji,et al.  E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8 , 2008, Nature.

[47]  Pablo Tamayo,et al.  CDK8 is a colorectal cancer oncogene that regulates β-catenin activity , 2008, Nature.

[48]  J. Treisman,et al.  Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13 , 2008, Proceedings of the National Academy of Sciences.

[49]  L. Hansen,et al.  Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis , 2008, Journal of Cell Science.

[50]  S. Cohen,et al.  microRNA functions. , 2007, Annual review of cell and developmental biology.

[51]  Seokjoong Kim,et al.  Mediator Is a Transducer of Wnt/β-Catenin Signaling* , 2006, Journal of Biological Chemistry.

[52]  D. Bigner,et al.  Recent advances in the treatment of malignant astrocytoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  G. Ruvkun.  Clarifications on miRNA and Cancer , 2006, Science.

[54]  Seokjoong Kim,et al.  Mediator is a transducer of Wnt/beta-catenin signaling. , 2006, The Journal of biological chemistry.

[55]  M. Barbacid,et al.  Mammalian cyclin-dependent kinases. , 2005, Trends in biochemical sciences.

[56]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.